Sadaki, Shunya
Tsuji, Ryosuke
Hayashi, Takuto
Watanabe, Masato
Iwai, Ryoto
Wenchao, Gu
Semenova, Ekaterina A.
Sultanov, Rinat I.
Zhelankin, Andrey V.
Generozov, Edward V.
Ahmetov, Ildus I.
Sakakibara, Iori
Ojima, Koichi
Sakurai, Hidetoshi
Muratani, Masafumi
Kudo, Takashi
Takahashi, Satoru
Fujita, Ryo
Funding for this research was provided by:
Japan Society for the Promotion of Science (23KJ0287, 24K02876)
Japan Agency for Medical Research and Development (JP20bm0804025, JP23gm171008h, JP23gm171008h)
Article History
Received: 28 March 2025
Accepted: 16 July 2025
First Online: 26 July 2025
Declarations
:
: The Russian part of the study was approved by the Ethics Committee of the Federal Research and Clinical Center of Physical–Chemical Medicine of the Federal Medical and Biological Agency of Russia (protocol no. 2017/04), whereas the Finnish part of the study was approved by the Hospital District of Helsinki and Uusimaa (Database of Genotypes and Phenotypes Study Accession: phs001048.v2.p1). Written informed consent was obtained from all study participants.
: Not applicable.
: TK and ST are inventors on a patent application related to this work (Patent Application No. 2022-083553). All other authors declare they have no competing interests.